Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
How to buy Stryker Corporation (SYK) stock
Learn how to easily invest in Stryker Corporation stock.
Stryker Corporation is a medical devices business based in the US. Stryker Corporation shares (SYK) are listed on the NYSE and all prices are listed in US Dollars. Stryker Corporation employs 43,000 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Stryker Corporation
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – SYK – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- SYK shares summary
- Compare share dealing platforms
- Is SYK stock a buy or sell?
- Stock performance over time
- Can I short SYK shares?
- Is SYK suitable for ethical investing?
- Are SYK shares over-valued?
- Stryker Corporation's financials
- How volatile are SYK shares?
- Does Stryker Corporation pay a dividend?
- Have SYK shares ever split?
- Other common questions
Stryker Corporation stock price (NYSE: SYK)Use our graph to track the performance of SYK stocks over time.
Stryker Corporation shares at a glance
|Latest market close||$249.74|
|52-week range||$183.28 - $267.39|
|50-day moving average||$258.58|
|200-day moving average||$249.21|
|Wall St. target price||$274.09|
|Dividend yield||$2.41 (0.93%)|
|Earnings per share (TTM)||$3.69|
Buy Stryker Corporation shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Stryker Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Stryker Corporation price performance over time
|1 week (2021-07-17)||N/A|
|1 month (2021-06-28)||-4.08%|
|3 months (2021-04-28)||-3.79%|
|6 months (2021-01-24)||N/A|
|1 year (2020-07-24)||N/A|
|2 years (2019-07-24)||N/A|
|3 years (2018-07-24)||N/A|
|5 years (2016-07-24)||N/A|
Is Stryker Corporation under- or over-valued?
Valuing Stryker Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Stryker Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Stryker Corporation's P/E ratio
Stryker Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 70x. In other words, Stryker Corporation shares trade at around 70x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Stryker Corporation's PEG ratio
Stryker Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.0609. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Stryker Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Stryker Corporation's EBITDA
Stryker Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $3.8 billion.
The EBITDA is a measure of a Stryker Corporation's overall financial performance and is widely used to measure a its profitability.
Stryker Corporation financials
|Revenue TTM||$14.7 billion|
|Operating margin TTM||20.05%|
|Gross profit TTM||$9.2 billion|
|Return on assets TTM||5.86%|
|Return on equity TTM||10.58%|
|Market capitalisation||$97.6 billion|
TTM: trailing 12 months
Shorting Stryker Corporation shares
There are currently 3.3 million Stryker Corporation shares held short by investors – that's known as Stryker Corporation's "short interest". This figure is 14.2% down from 3.9 million last month.
There are a few different ways that this level of interest in shorting Stryker Corporation shares can be evaluated.
Stryker Corporation's "short interest ratio" (SIR)
Stryker Corporation's "short interest ratio" (SIR) is the quantity of Stryker Corporation shares currently shorted divided by the average quantity of Stryker Corporation shares traded daily (recently around 1.1 million). Stryker Corporation's SIR currently stands at 3.16. In other words for every 100,000 Stryker Corporation shares traded daily on the market, roughly 3160 shares are currently held short.
However Stryker Corporation's short interest can also be evaluated against the total number of Stryker Corporation shares, or, against the total number of tradable Stryker Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Stryker Corporation's short interest could be expressed as 0.01% of the outstanding shares (for every 100,000 Stryker Corporation shares in existence, roughly 10 shares are currently held short) or 0.01% of the tradable shares (for every 100,000 tradable Stryker Corporation shares, roughly 10 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Stryker Corporation.
Find out more about how you can short Stryker Corporation stock.
Stryker Corporation's environmental, social and governance track record
Environmental, social and governance (known as ESG) criteria are a set of three factors used to measure the sustainability and social impact of companies like Stryker Corporation.
When it comes to ESG scores, lower is better, and lower scores are generally associated with lower risk for would-be investors.
Stryker Corporation's total ESG risk score
Total ESG risk: 33.93
Socially conscious investors use ESG scores to screen how an investment aligns with their worldview, and Stryker Corporation's overall score of 33.93 (as at 12/31/2018) is pretty weak – landing it in it in the 71st percentile of companies rated in the same sector.
ESG scores are increasingly used to estimate the level of risk a company like Stryker Corporation is exposed to within the areas of "environmental" (carbon footprint, resource use etc.), "social" (health and safety, human rights etc.), and "governance" (anti-corruption, tax transparency etc.).
Stryker Corporation's environmental score
Environmental score: 3.06/100
Stryker Corporation's environmental score of 3.06 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector terms of its environmental impact, and exposed to a lower level of risk.
Stryker Corporation's social score
Social score: 14.68/100
Stryker Corporation's social score of 14.68 puts it squarely in the 1st percentile of companies rated in the same sector. This could suggest that Stryker Corporation is a leader in its sector when it comes to taking good care of its workforce and the communities it impacts.
Stryker Corporation's governance score
Governance score: 8.19/100
Stryker Corporation's governance score puts it squarely in the 1st percentile of companies rated in the same sector. That could suggest that Stryker Corporation is a leader in its sector when it comes to responsible management and strategy, and exposed to a lower level of risk.
Stryker Corporation's controversy score
Controversy score: 3/5
ESG scores also evaluate any incidences of controversy that a company has been involved in. Stryker Corporation scored a 3 out of 5 for controversy – a middle-of-the-table result reflecting that Stryker Corporation hasn't always managed to keep its nose clean.
Environmental, social, and governance (ESG) summary
|Total ESG score||33.93|
|Total ESG percentile||70.66|
|Environmental score percentile||1|
|Social score percentile||1|
|Governance score percentile||1|
|Level of controversy||3|
Stryker Corporation share dividends
Dividend payout ratio: 32.78% of net profits
Recently Stryker Corporation has paid out, on average, around 32.78% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.97% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Stryker Corporation shareholders could enjoy a 0.97% return on their shares, in the form of dividend payments. In Stryker Corporation's case, that would currently equate to about $2.41 per share.
While Stryker Corporation's payout ratio might seem fairly standard, it's worth remembering that Stryker Corporation may be investing much of the rest of its net profits in future growth.
Stryker Corporation's most recent dividend payout was on 29 July 2021. The latest dividend was paid out to all shareholders who bought their shares by 28 June 2021 (the "ex-dividend date").
Have Stryker Corporation's shares ever split?
Stryker Corporation's shares were split on a 2:1 basis on 16 May 2004. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Stryker Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Stryker Corporation shares which in turn could have impacted Stryker Corporation's share price.
Stryker Corporation share price volatility
Over the last 12 months, Stryker Corporation's shares have ranged in value from as little as $183.2791 up to $267.3914. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Stryker Corporation's is 0.9739. This would suggest that Stryker Corporation's shares are less volatile than average (for this exchange).
Stryker Corporation overview
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries.
Stocks similar to Stryker Corporation
Stryker Corporation in the news
Stocks That Hit 52-Week Highs On Wednesday
Stryker Boosts Q2 Earnings, Margins After Clocking 55% Jump In Sales As Pandemic Moderates
Stryker Corp (SYK) Q2 2021 Earnings Call Transcript
Frequently asked questionsWhat percentage of Stryker Corporation is owned by insiders or institutions?
Currently 7.31% of Stryker Corporation shares are held by insiders and 75.24% by institutions. How many people work for Stryker Corporation?
Latest data suggests 43,000 work at Stryker Corporation. When does the fiscal year end for Stryker Corporation?
Stryker Corporation's fiscal year ends in December. Where is Stryker Corporation based?
Stryker Corporation's address is: 2825 Airview Boulevard, Kalamazoo, MI, United States, 49002 What is Stryker Corporation's ISIN number?
Stryker Corporation's international securities identification number is: US8636671013 What is Stryker Corporation's CUSIP number?
Stryker Corporation's Committee on Uniform Securities Identification Procedures number is: 863667101
More guides on Finder
How to buy Clover Finance (CLV) in the US
This guide will show you step-by-step instructions on how to buy the Clover Finance (CLV) token as well as a list of exchanges you can trade it on.
How to buy AT-and-T (T) stock
Steps to owning and managing T, with 24-hour and historical pricing before you buy.
How to buy HNC Coin (HNC) in the US
This guide will show you step-by-step instructions on how to buy the Hellenic Coin (HNC) token as well as a list of exchanges you can trade it on.
How to buy Maro (MARO) in the US
This guide will show you step-by-step instructions on how to buy the Maro (MARO) token as well as a list of exchanges you can trade it on.
How to buy Ethernity Chain (ERN) in the US
This guide will show you step-by-step instructions on how to buy the Ethernity Chain (ERN) token as well as a list of exchanges you can trade it on.
How to buy Shopping.io (SPI) in the US
This guide will show you step-by-step instructions on how to buy the Shopping.io (SPI) token as well as a list of exchanges you can trade it on.
How to buy LUKSO Token (LYXE) in the US
This guide will show you step-by-step instructions on how to buy the LUKSO Token (LYXE) token as well as a list of exchanges you can trade it on.
How to buy KardiaChain (KAI) in the US
This guide will show you step-by-step instructions on how to buy the KardiaChain (KAI) token as well as a list of exchanges you can trade it on.
How to buy Neutrino USD (USDN) in the US
This guide will show you step-by-step instructions on how to buy the Neutrino USD (USDN) token as well as a list of exchanges you can trade it on.
How to buy Venus BTC (VBTC) in the US
This guide will show you step-by-step instructions on how to buy the Venus BTC (VBTC) token as well as a list of exchanges you can trade it on.
Ask an Expert